an>, San Diego
, New York City
, Suburban Washington, D.C.
, and Research Triangle Park. Alexandria
's high-credit client tenants span the life science industry, including renowned academic medical research centers, multinational pharmaceutical companies, public and private biotechnology entities, U.S. government research agencies, medical device companies, industrial biotechnology companies, venture capitalists, and life science product and service companies. Forty-seven percent of Alexandria
's total annualized base rent is from investment-grade client tenants. As the recognized real estate partner of the life science industry, Alexandria
has a superior track record in driving client tenant productivity, collaboration, and innovation through its CBD locations adjacent to leading academic medical research centers, best-in-class laboratory/office space, unparalleled life science real estate expertise and services, and longstanding and expansive network in the life science community, which we believe result in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value. For more information, please visit www.are.com
This press release contains forward-looking statements within the meaning of the federal securities laws. Actual results may differ materially from those projected in the forward-looking statements. Additional information concerning factors that could cause actual results to differ materially from those in the forward-looking statements is contained in our Annual Report on Form 10-K and our other periodic reports filed with the Securities and Exchange Commission.
Page: 1 2 3 Related biology technology :1
|SOURCE Alexandria Real Estate Equities, Inc.|
Copyright©2012 PR Newswire.
All rights reserved
. Verenium Corporation And Alexandria Real Estate Equities, Inc. Celebrate The Grand Opening Of A New State-of-the-art Biotechnology Facility2
. Genomatica, Inc., Award-Winning Industrial Biotechnology Pioneer, Selects Alexandria Real Estate Equities, Inc. for Long-Term, Mission-Critical R&D Facility and Corporate Headquarters3
. Regulus Receives Allowance from Japan and U.S. Patent Offices for HCV Intellectual Property, Expanding Leading Worldwide Patent Estate4
. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting5
. VaxyGen Assay Services, LLC Announces Launch of Custom Bioassay Services and Operations6
. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference7
. ACORN Research, LLC Announces Partnership with AdeptBio, LLC8
. GeoVax Labs, Inc. Announces Nine Month 2011 Financial Results9
. WuXi PharmaTech Announces Third-Quarter 2011 Results10
. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting11
. Spherix Announces Third Quarter Financial Results